GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **651 - 675** of **4050** in total

« First

‹ Prev

…

23

24

25

26

27

28

29

30

31

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgM	Patient 1	6	moderate	G89993FE	43
IgG	Patient 2	15	mild	G29011JC	43
IgM	Patient 2	24	mild	G12200GB	43
IgG	Patient 2	3	mild	G08520NM	43
IgG	Patient 2	3	mild	G25473LQ	43
IgG	Patient 2	3	mild	G67045LB	43
IgG	Patient 2	3	mild	G76355TG	43
IgG	Patient 3	-180	mild	G54064FW	43
IgG	Patient 3	-180	mild	G82779CI	43
IgG	Patient 3	11	mild	G09609EN	43
IgG	Patient 3	11	mild	G29011JC	43
IgG	Patient 3	4	mild	G00048MO	43
IgG	Patient 1	22	moderate	G36374CE	44
IgG	Patient 1	22	moderate	G49916XD	44
IgG	Patient 1	22	moderate	G92022ML	44
IgM	Patient 1	10	moderate	G10789DJ	44
IgM	Patient 1	10	moderate	G19868AX	44
IgM	Patient 1	10	moderate	G21460SG	44
IgM	Patient 1	10	moderate	G25473LQ	44
IgM	Patient 1	10	moderate	G40696TO	44
IgM	Patient 1	10	moderate	G47566FL	44
IgM	Patient 1	10	moderate	G51872EK	44
IgG	Patient 2	15	mild	G78074HX	44
IgG	Patient 2	15	mild	G82779CI	44
IgG	Patient 2	24	mild	G39023AU	44